logo
Send Message

products details

Created with Pixso. Home Created with Pixso. Products Created with Pixso.
Infectious Disease Testing
Created with Pixso.

SARS-CoV-2 Neutralization Antibody Rapid Test

SARS-CoV-2 Neutralization Antibody Rapid Test

Brand Name: AllTest
Model Number: REF ICN-402
Payment Terms: T/T
Detail Information
Place of Origin:
China
Certification:
CE
Principle:
Chromatographic Immunoassay
Specimen:
WB/S/P
Reading Time:
10 Minutes
Format:
Cassette
Sensitivity:
96.6%
Specificity:
98.5%
Accuracy:
97.7%
Packaging Details:
25T
Highlight:

Neutralization Antibody Rapid Test

,

SARS-CoV-2 Antibody Rapid Test

,

SARS-CoV-2 Infectious Disease Testing

Product Description

SARS-CoV-2 Neutralization Antibody Rapid Test

【DIRECTIONS FOR USE】
Allow the test, specimen, buffer and/or controls to equilibrate to room
temperature (15-30°C) prior to testing.
1. Take out the test from the foil pouch and use it as soon as possible. Best results will
be obtained if the assay is performed within one hour.
2. Place the test on a flat and clean surface.
For Serum or Plasma specimen:
•Use a dropper: Hold the dropper vertically and transfer 2 drops of serum or plasma
(approximately 50uL) to the specimen well (S). Start the timer.
•Use a pipette: Transfer 50uL of serum or plasma to the specimen well(S), then
start the timer.
For Whole Blood specimen:
•Use a dropper: Hold the dropper vertically and transfer 3 drops of whole blood
(approximately 75uL) to the specimen well (S). Then add 1 drop of buffer
(approximately 40uL) and start the timer.
•Use a pipette: Transfer 75uL of whole blood to the specimen well(S), then add 1
drop of buffer (approximately 40uL) and start the timer.
3. Wait for the colored line(s) to appear. Read results at 10 minutes. Do not interpret
the result after 20 minutes.

SARS-CoV-2 Neutralization Antibody Rapid Test 2

The SARS-CoV-2 Neutralization Antibody Rapid Test (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay intended for the qualitative detection of neutralization antibodies against SARS-CoV-2 that block the interaction between the receptor binding domain of the viral spike glycoprotein (RBD) with the cell surface receptor ACE2 in human whole blood, serum or plasma. It is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2.

 

SARS-CoV-2 Neutralization Antibody Rapid Test 3